Houston Methodist Neurological Institute

Houston, Texas 77070

9 studies enrolling now · 43 studies all time

What they study most

ALS, Acute Ischemic Stroke (AIS), Acute Non-cardioembolic Ischemic Stroke, Acute Stroke, Agitation in Participants With Dementia of the Alzheimer's Type, Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Anaplastic Astrocytoma, Astrocytoma, Grade III, Atypical Parkinsonism, Cerebrospinal Fluid Leak

Studies at this site

• 18F-mFBG Cardiac Uptake With Lewy Body Dementia — Recruiting now
• A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG) — Recruiting now
• Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) — Recruiting now
• Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) — Recruiting now
• AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis — Recruiting now
• HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM — Recruiting now
• HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM — Recruiting now
• A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 — Enrolling by invitation
• Safety Study of Oral Edaravone Administered in Subjects With ALS — Completed
• A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis — Running, not enrolling
• Trial of Parkinson's And Zoledronic Acid — Completed
• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid — Running, not enrolling
• To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications — Running, not enrolling
• Study of the Safety and Neuroprotective Capacity of Scp776 in Acute Ischemic Stroke — Completed
• Global Study of Del-desiran for the Treatment of DM1 — Running, not enrolling
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease — Running, not enrolling
• Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Stopped early
• A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation — Stopped early
• Memory Improvement Through Nicotine Dosing (MIND) Study — Completed
• A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease — Running, not enrolling
• PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 — Stopped early
• STEM-PD Open Label Extension (OLE) — Stopped early
• Alzheimer's Plasma Extension — Running, not enrolling
• STEM-Parkinson's Disease — Completed
• Spinraza in Adult Spinal Muscular Atrophy — Running, not enrolling
• RoBotic TCD Ultrasound BubbLe Study Compared to Transthoracic Echocardiography for Detection of Right to Left Shunt — Completed
• Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease — Completed
• Multiple Doses of AT-1501-A201 in Adults With ALS — Completed
• Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) — Completed
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type — Completed
• Genomic Translation for Amyotrophic Lateral Sclerosis Care — Completed
• Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS) — Completed
• A Phase 2 RCT Study of CX-8998 for Essential Tremor — Completed
• The Dystonia Coalition Natural History and Biospecimen Repository for Isolated Dystonias — Completed
• Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis — Completed
• Advanced MRI Applications for Mild Traumatic Brain Injury-Phase 2 — Completed
• Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery — Completed
• A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis — Completed
• Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation — Completed
• TBI MR Study 3 Houston Methodist — Stopped early